- Home
- RVPH vs COCH Comparison
RVPH vs COCH Comparison
Compare RVPH & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- COCH
- Stock Information
- Founded
- RVPH 2006
- COCH 1995
- Country
- RVPH United States
- COCH United States
- Employees
- RVPH N/A
- COCH N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- COCH Blank Checks
- Sector
- RVPH Health Care
- COCH Finance
- Exchange
- RVPH Nasdaq
- COCH Nasdaq
- Market Cap
- RVPH 32.8M
- COCH 31.6M
- IPO Year
- RVPH N/A
- COCH N/A
- Fundamental
- Price
- RVPH $0.38
- COCH $1.62
- Analyst Decision
- RVPH Strong Buy
- COCH Strong Buy
- Analyst Count
- RVPH 5
- COCH 2
- Target Price
- RVPH $9.00
- COCH $9.25
- AVG Volume (30 Days)
- RVPH 3.8M
- COCH 28.0K
- Earning Date
- RVPH 08-13-2025
- COCH 08-11-2025
- Dividend Yield
- RVPH N/A
- COCH N/A
- EPS Growth
- RVPH N/A
- COCH N/A
- EPS
- RVPH N/A
- COCH N/A
- Revenue
- RVPH N/A
- COCH $212,000.00
- Revenue This Year
- RVPH N/A
- COCH $5.93
- Revenue Next Year
- RVPH N/A
- COCH $17.69
- P/E Ratio
- RVPH N/A
- COCH N/A
- Revenue Growth
- RVPH N/A
- COCH N/A
- 52 Week Low
- RVPH $0.30
- COCH $1.21
- 52 Week High
- RVPH $4.28
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- RVPH 34.83
- COCH 58.84
- Support Level
- RVPH $0.38
- COCH $1.43
- Resistance Level
- RVPH $0.45
- COCH $1.59
- Average True Range (ATR)
- RVPH 0.05
- COCH 0.12
- MACD
- RVPH 0.01
- COCH 0.02
- Stochastic Oscillator
- RVPH 52.37
- COCH 55.00
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.